Global Fungal Foot Drug Market Size, Share and Trends Analysis Report, By Type (Cream, Spray, and Others), By Application (Offline Store and Online Store), Forecast (2022-2028)

The global fungal foot drug market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Fungal infections are called athlete’s foot as they are more common in athletes. Additionally, the athlete’s easy availability of over-the-counter medications, new product growth, and lower costs are likely to increase the fungal foot drug market demand during the forecast period. The market demand for athlete drugs is hampered by a lack of knowledge and treatment options. The proliferation of athlete’s feet in well-established health care facilities and the awareness of high athletes’ foot may have led to a greater share of the forecasting while serving as an opportunity for the fungal foot drug market to grow.

The fungal infection of the feet causes the scaling and blistering of the soles, cracks at the toes, and painful and burning sensations along itching rashes. A major factor in the market growth is the rising prevalence and increasing incidence rates of fungal foot drugs across the globe. According to the National Center for Biotechnology Information (NCBI), a fungal foot is very common with an affection rate of 3.0% to 15.0% of the population. According to the same source, men and older people are more likely to get it. The increasing prevalence of this infection is driving the growth of the global fungal foot drugs market during the forecast period. In addition,  the market is improving due to the easy availability of over-the-counter treatment combined with lower treatment costs.

The increase in the prevalence of fungal infections across the globe has prompted manufacturers to develop improved synthetic drugs for better clinical outcomes. It is in turn encourages market growth during forecasted period. The manufacturers are focusing on the advanced development of drugs that can be developed with the help of nanotechnology. Nanotechnology is widely used in various medical fields to deliver improved patient outcomes. For example, nanotechnology is used to treat nail fungus that causes nail damage, pain, and other problems. In addition, players are focusing on the development of drugs such as Amphotericin B. It is a topical nanoemulsion Antifungal drug for the treatment of candidiasis and aspergillosis, thereby leading to market growth.

Looking toward the market growth opportunities in April 2018, Sun Pharmaceutical Industries Ltd. introduced an Antifungal powder name Abzorb to treat fungal infections of the skin including worms, jock itch, and fungal foot. The product is considered both medical prescription and over-the-counter.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Type
  • By Application
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape– Bayer AG, Crown Laboratories, Johnson & Johnson, Novartis International AG, and Taro Pharmaceutical, among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Fungal Foot Drugs Market Report by Segment

By Type

• Cream
• Spray
• Others

By Application

• Offline Store
• Online Store

Global Fungal Foot Drugs Market Report by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa